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The genome of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) contains eight
open reading frames (ORFs) that encode novel proteins. These accessory proteins are dispensable for in vitro
and in vivo replication and thus may be important for other aspects of virus-host interactions. We investigated
the functions of the largest of the accessory proteins, the ORF 3a protein, using a 3a-deficient strain of
SARS-CoV. Cell death of Vero cells after infection with SARS-CoV was reduced upon deletion of ORF 3a.
Electron microscopy of infected cells revealed a role for ORF 3a in SARS-CoV induced vesicle formation, a
prominent feature of cells from SARS patients. In addition, we report that ORF 3a is both necessary and
sufficient for SARS-CoV-induced Golgi fragmentation and that the 3a protein accumulates and localizes to
vesicles containing markers for late endosomes. Finally, overexpression of ADP-ribosylation factor 1 (Arf1), a
small GTPase essential for the maintenance of the Golgi apparatus, restored Golgi morphology during
infection. These results establish an important role for ORF 3a in SARS-CoV-induced cell death, Golgi
fragmentation, and the accumulation of intracellular vesicles.
The severe acute respiratory syndrome-associated coronavi-
rus (SARS-CoV) genome encodes several smaller open read-
ing frames (ORFs) located in the 3 region of the genome that
are predicted to express eight novel proteins termed accessory
proteins. The accessory proteins are designated ORFs 3a, 3b,
6, 7a, 7b, 8a, 8b, and 9b and range in size from 39 to 274 amino
acids (35, 50). These SARS-CoV-specific ORFs are not present in
other coronaviruses and do not display significant homology
with any known proteins in the NCBI database. Five of these
are predicted to code for polypeptides of greater than 50 amino
acids (35, 50). Antibodies reactive against all of the SARS-
CoV proteins have been detected in sera isolated from SARS
patients, indicating that these proteins are expressed by the
virus in vivo (7, 9, 17–19, 45, 59). Expression of three of the
ORF proteins has been demonstrated during infection using
protein-specific antibodies and include the ORFs 3a, 6, and 7a
(12, 37, 41, 60). Six of the eight group-specific ORFs, including
ORFs 3a, 3b, 6, 7a, 7b, and 9b, were deleted from recombinant
SARS-CoV and shown to be dispensable for in vitro and in
vivo replication (66).
Related coronaviruses also encode unique accessory pro-
teins in the 3 region of the genome, often referred to as
group-specific ORFs. Similar to SARS-CoV, several of these
proteins are dispensable for viral replication. Murine hepatitis
virus (MHV) expresses accessory proteins ORFs 2a, 4, and 5a.
A recombinant virus in which ORF 2a was deleted replicated
normally in vitro but caused attenuated disease in vivo (55).
Deletion of the group-specific ORF 7 in porcine coronavirus
TGEV also results in reduced replication and virulence in vivo
despite normal replication in vitro (38). Similarly, in feline
infectious peritonitis virus (FIPV), group-specific proteins are
dispensable for replication in cell culture but contribute to
pathogenesis in vivo (20). Thus, while the SARS-CoV group
specific proteins are unnecessary for in vitro and in vivo rep-
lication, their expression may underlie the devastating pathol-
ogy associated with SARS disease. Detailed characterization of
these novel proteins may contribute to a better understanding
of SARS pathogenesis and host-virus interactions.
The ORF 3a protein is expressed from subgenomic RNA3,
which contains the 3a and 3b ORFs (35, 50). The 3a protein,
which is the largest group-specific SARS-CoV accessory pro-
tein at 274 amino acids, has been reported to localize to the
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Golgi apparatus, the plasma membrane, and intracellular ves-
icles of unknown origin (67, 68). The protein is efficiently
transported to the cell surface and is also internalized during
the process of endocytosis (60).
The mechanism of SARS-CoV-induced cell death has been
investigated by several groups. Studies to date have used over-
expression of individual SARS-CoV ORFs to evaluate their
intrinsic cytotoxicity. Using this approach, the following pro-
teins have been reported to cause apoptosis: the 3CL-like
protease; spike; ORFs 3a, 3b, and 7a; and the envelope (E),
membrane (M), and nucleocapsid (N) proteins (23, 31, 32, 36,
46, 58, 61, 65, 69). However, since all of these reports utilize
overexpression of individual proteins, it is unclear whether
these effects may be attributable to high, nonphysiological lev-
els of protein and whether they occur during infection. Anal-
ysis of recombinant viruses with specific mutations or deletions
is necessary to determine the relative contribution of these
proteins to the cytotoxicity of SARS-CoV during infection
(63). Therefore, the cytotoxic component(s) of SARS-CoV
have not been fully defined.
Here, we have investigated the function of the ORF 3a
protein in the context of SARS-CoV infection and by overex-
pression. We confirm that ORF 3a contributes to SARS-CoV
cytotoxicity using a recombinant strain deficient for expression
of ORF 3a. While characterizing this deficient strain, we ob-
served that SARS-CoV-induced vesicle formation, a feature
that has been documented in cells from infected SARS pa-
tients, is dependent on ORF 3a. Furthermore, we observed
that SARS-CoV infection causes Golgi fragmentation by ORF
3a. Additional characterization of 3a in transfected cells re-
vealed that the protein colocalizes with markers of the trans-
Golgi network (TGN) and late endosomal pathways and
causes an accumulation of these vesicles. Finally, we report
that Arf1 overexpression rescued SARS-CoV or 3a-induced
Golgi fragmentation, suggesting that the ORF 3a protein may
perturb Arf1-mediated vesicle trafficking.
MATERIALS AND METHODS
Cell lines and viruses. Vero cells were obtained from the American Type
Culture Collection (Rockville, MD). Cells were maintained in Dulbecco modi-
fied Eagle medium with 4.5 g of glucose/liter, supplemented with 2 mM L-
glutamine, 1% penicillin-streptomycin solution, and 10% fetal bovine serum. The
construction and characterization of ORF3a SARS-CoV has been described
elsewhere (66). Vero cell monolayers were infected with SARS-CoV (Urbani
strain), ORF3a SARS-CoV at a multiplicity of infection of 5. All work with
infectious SARS-CoV virus was performed in a biosafety level 3 facility by
personnel wearing powered air purifying respirators (3M HEPA AirMate, Saint
Paul, MN).
Plasmids and DNA transfection. An expression construct for SARS-CoV 3a
was generated by using RNA extracted from SARS-CoV-infected Vero cells.
Reverse transcription (RT) followed by PCR was carried out by with the follow-
ing gene specific primers: forward primer, 5-CCGGAATTCAGATTTTTTAC
TCTTAGATC-3, and reverse primer, 5-TCCCCCCGGGCCAAAGGCACGC
TAGTAGTCG-3.
The resulting PCR products were cloned into the EcoRI-XmaI sites of the
p3xFlag-green fluorescent protein (GFP) vector, which is expressed under the
cytomegalovirus promoter. The fidelity of the resulting construct was confirmed
by sequencing. Expression constructs for Arf1 and Gal have been described
elsewhere (33). GFP-LC3 was kindly provided by N. Mizushima and T. Yoshi-
mori and RFP-LC3 was kindly provided by Marja Jaattela. Vero cells (106) were
transfected with 1 g of DNA (single transfections) or 0.5 g of each plasmid
(cotransfections) by Amaxa nucleofection, using V solution, program O-17
(Gaithersburg, MD). HEK293T cells were transfected by the calcium phosphate
precipitation method using 2 g of DNA.
Detection of SARS-CoV nucleic acid. Detection and quantification of SARS-
CoV was determined by using a QuantiTect Probe RT-PCR kit (catalog no.
204443; Qiagen, Valencia, CA) according to the manufacturer’s protocol. In
brief, RNA samples were quantified with a spectrophotometer (Agilent Tech-
nologies, Palo Alto, CA) and an aliquot diluted to a concentration of 100 ng/l
in preparation for real-time RT-PCR analyses. Each 50-l reaction mixture
contained 25 l of 2 Master Mix; 0.5 l of RT mix; SARS N3-specific primers
and probe (forward, 5-GAA GTA CCA TCT GGG GCT GAG-3; reverse,
5-CCG AAG AGC TAC CCG ACG-3; probe, 5-HEX-CTC TTT CAT TTT
GCC GTC ACC ACC AC-BHQ1-3) at final concentrations of 0.4 and 0.2 M,
FIG. 1. Cell death caused by SARS-CoV is reduced by deletion of 3a. (A) Vero cells were mock infected (MOCK) or infected with wild-type
(WT) or 3a-deficient (3a) SARS-CoV. After 48 h, cells were examined by phase-contrast light microscopy. (B) Quantification of cell death in
samples in panel A after trypan blue staining. (C) Amplification of viral nucleic acid in medium and cells of samples in panel A determined by
quantitative real-time PCR and represented as the mean threshold cycle normalized by 18S rRNA.
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respectively; 18.5 l of nuclease-free water; and 1 l of RNA (100 ng) that was
heat denatured at 95°C for 2 min on a PTC-100 Peltier thermal cycler (MJ
Research, Waltham, MA) prior to addition. Amplification was carried out in
96-well plates on a Mx4000 multiplex quantitative PCR system (Stratagene, La
Jolla, CA). Thermocycling conditions consisted of 30 min at 50°C for RT; 15 min
at 95°C for polymerase activation; and 40 cycles of 30 s at 95°C, 1 min at 56°C,
and 30 s at 76°C. Each sample was also run under identical conditions with
primers and probe specific for the 18S housekeeping gene (forward, 5-GGT
ACA GTG AAA CTG CGA AT-3; reverse, 5-CAG TTA TCC AAG TGG
GAG AG-3; probe, 5-6-FAM-ATT AAA TCA GTT ATG GTT CCT TTG
GTC G-BHQ-6-FAM-3). A 10-fold serial dilution standard curve was generated
for each set of primers with the Urbani strain of SARS-CoV (1.55  105 50%
tissue culture infective doses/l).
Microscopy. Transfected cells were subcultured in a four-chamber borosilicate
chambered coverglass system (Nunc), fixed with 4% paraformaldehyde in phos-
phate-buffered saline (pH 7.4), and analyzed under a confocal fluorescence
microscope (Leica SP2-AOBS-UV405; Leica Microsystems, Wetzlar, Germany)
or imaged live while maintaining cells at 37°C and 5% CO2 with a heated stage.
Cells were imaged by using a 63 objective with 3 digital zoom or 63
objective with 1 digital zoom for high and low magnifications, respectively.
Anti-GM130 monoclonal antibody was obtained from Becton Dickinson Trans-
duction Laboratories (Franklin Lakes, NJ). For staining for GM130, cells were
fixed, permeabilized, and stained by using permeabilization solution and blocking
solution from Molecular Probes according to the instructions. Primary and sec-
ondary antibodies were diluted 1:1,000. For evaluation of morphology of the
Golgi apparatus, cells were imaged at random using a 63 objective lens. Then,
using ImageJ software, the numbers of cells per field containing a bright and
distinct juxtanuclear Golgi stack or a dispersed Golgi apparatus were deter-
mined. Electron microscopy was carried out as described previously (16). Briefly,
cells were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4),
postfixed in 1% osmium tetroxide for 1 h, embedded in Epon-substitute/araldite
resin, sectioned, double stained with uranyl acetate and lead citrate, and ana-
lyzed using a Philips 410LS transmission electron microscope. For each treat-
ment or control group, at least 100 cells from randomly chosen transmission
electron microscopy (TEM) fields were analyzed for quantification of morpho-
logical features.
RESULTS
ORF 3a contributes to cell death caused by SARS-CoV.
Previous reports have documented cell death as a result of
overexpression of ORF 3a (31, 39). To determine the physio-
logical importance of ORF 3a, we infected Vero cells with
wild-type (WT) or 3a-deficient (3a) SARS-CoV, which has
been described previously (66). At 48 h postinfection (hpi), we
observed a reduction in cell death for 3a compared to the WT
(Fig. 1A and B). To determine whether the observed reduction
in cell death was a result of impaired replication of the virus,
we assessed the levels of intracellular and extracellular viral
RNA by real-time PCR. We observed that RNA levels and
titers were equivalent for both strains, indicating that reduced
cell death was unlikely a consequence of impaired replication
(Fig. 1C). These results are in agreement with a previous
report that reported equivalent replication for 3a and WT
virus in Vero cells, assessed by plaque assay, at 32 hpi (66).
Thus, 3a contributes to SARS-CoV-induced cell death during
infection.
ORF 3a is necessary for the formation of intracellular
vesicles. SARS-CoV induces extensive rearrangement of host
cellular membranes, which may serve as sites for viral RNA
replication and protect replicating virus from host immune
responses (15, 53). A reticulovesicular network of modified
endoplasmic reticulum (ER) containing vesicles and convo-
luted membranes has recently been characterized in SARS-
CoV-infected cells (27). However, the mechanism of mem-
brane rearrangement and vesicle formation remains poorly
understood. By TEM analysis, we observed that Vero cells
infected with WT SARS-CoV for 24 and 48 h also exhibit
vesicles similar to those found in published images of human
cells analyzed ex vivo (Fig. 2 and Fig. 3A) (15). These vesicles
are primarily localized in the juxtanuclear region of the cell
and are largely devoid of contents, which is likely due to the
fixation methodology since others have reported different re-
sults using cryofixation and freeze substitution (54). Most ves-
icles appeared to be surrounded by a single membrane and
therefore might not have originated by the cellular process of
autophagy. Strikingly, vesicles were absent in cells infected
FIG. 2. SARS-CoV-infected cells exhibit cytoplamsic vesicles. (A
and B) Vero cells were infected for 48 h with WT SARS-CoV and were
fixed and analyzed by TEM. Infected cells show numerous vesicles and
vacuoles and do not show characteristics of apoptosis such as reduction
in cytoplasmic volume or nuclear condensation.
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with 3a SARS-CoV (Fig. 3B). Intracellular virus particles
were visible and present in similar quantities in cells infected
by both strains (Fig. 3B, lower panel). Thus, these results
indicate that 3a expression is required for vesicle formation.
SARS-CoV causes fragmentation of the Golgi apparatus by
ORF 3a. Since we observed that ORF 3a was necessary for
vesicle formation and an important contributor to virus-in-
duced cell death, we next investigated the role of vesicle for-
FIG. 3. Membrane rearrangement and vesicle formation by SARS-CoV is dependent on 3a. (A) Vero cells were infected with WT SARS-CoV
and 24 hpi were fixed and analyzed by TEM. Boxed region contains paranuclear vesicles. N, nucleus. (B) TEM of Vero cells either mock infected
(MOCK) or infected with wild-type (WT) or 3a SARS-CoV (3a) viruses as indicated. Higher magnifications of boxed paranuclear regions of
WT and 3a SARS-CoV-infected cells are shown in the lower panels. Membrane-bound vesicles (thick arrow) and virus particles (thin arrows)
are shown (bar, 1 m). The lower left panel shows histograms representing the fraction of cells containing vacuoles based on TEM.
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mation and their origin in infected and dying cells. Possible
sources of intracellular vesicles include the ER, Golgi appara-
tus, autophagic vesicles, and the plasma membrane via the
endocytic pathway. Other coronaviruses have been shown to
interact with the Golgi apparatus or ER-Golgi intermediate
compartment (ERGIC) to acquire the viral envelope (26).
While investigating the impact of virus infection on organelle
morphology, we found that SARS-CoV infection of Vero cells
caused fragmentation of the Golgi apparatus. Upon infection
with WT SARS-CoV, the Golgi structural proteins galactosyl-
transferase (Gal) and GM130 redistributed from a paranuclear
stack to dispersed vesicles (Fig. 4A and C). Since ORF 3a is
important for vesicle formation, we also evaluated the role of
ORF 3a in Golgi fragmentation. Infection of Vero cells with
WT SARS-CoV induced Golgi fragmentation in 74% of cells
compared to a background level of 21% in mock-infected cells.
Golgi fragmentation was reduced to 34% when cells were
infected with 3a SARS-CoV (Fig. 4B). These data show that
FIG. 4. Golgi fragmentation caused by SARS-CoV infection depends on 3a. (A) Vero cells were transfected with Golgi marker Gal-CFP and
after 24 h were mock infected (MOCK) or infected with SARS-CoV (WT) or 3a SARS-CoV (3a) at a multiplicity of infection of 5 and examined
by confocal microscopy at 24 hpi. The lower panels show higher magnifications of infected cells and intact juxtanuclear Golgi stacks (white arrows).
(B) Histogram showing the fraction of cells that contain fragmented Golgi (percent fragmented Golgi)  the standard deviation based on confocal
microscopy analysis as described in Materials and Methods (n  100 cells) in three replicates. (C) Cells were infected as in panel A. After 24 h,
cells were fixed and stained for GM130 and examined by confocal microscopy. White arrows indicate examples of cells that display what was
designated “fragmented Golgi.”
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FIG. 5. Expression of SARS-CoV 3a is sufficient to cause cell death, vesicle formation, and Golgi fragmentation. (A) Vero cells transfected with
3a-GFP were examined by confocal microscopy 48 hpt after propidium iodide (PI) staining to identify dead cells. (B) GFP or 3a-GFP transfected
cells were harvested at 48 hpt, and cell death was calculated. (C) Vero cells were transfected with 3a-GFP and harvested for TEM analysis 24 h
after transfection. Panel b is an enlargement of the boxed region in panel a and depicts juxtanuclear vesicles similar to those seen after infection
with SARS-CoV. (Scale bars: a, 2 m; b, 0.5 m) (D) Fluorescence photomicrographs of cells cotransfected with GFP alone and the Golgi marker
Gal-CFP fusion protein (a to c), pseudocolored in red or the 3a-GFP fusion protein and Gal-CFP (d to f), or 3a-GFP and stai ned for the Golgi
protein GM130 (g to i) and examined by confocal microscopy at 24 hpt. The boxed regions in panel f depict areas of colocalized and noncolocalized
protein.
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the ORF 3a glycoprotein contributes to Golgi fragmentation
during SARS-CoV infection.
Overexpression of ORF 3a is sufficient to cause cell death,
vesicle formation, and Golgi fragmentation. Having docu-
mented the importance of 3a in the processes of cell death,
vesicle formation, and Golgi fragmentation using the 3a-defi-
cient virus, we next wanted to determine whether the protein
was capable of inducing similar effects when overexpressed or
might require additional SARS-CoV proteins. Consistent with
published reports, we also observed that overexpression of
ORF 3a as a fusion protein with the green fluorescent protein
(3a-GFP) caused pronounced cell death compared to GFP
control (Fig. 5A and B) (31, 39). TEM analysis of transfected
cells showed the presence of intracellular vesicles similar to
those seen during infection with SARS-CoV (Fig. 5C). Over-
expression of ORF 3a also caused Golgi fragmentation, also
indicated by the redistribution of Gal and GM130 from a
juxtanuclear stack, as seen in control cells, to dispersed vesicles
(Fig. 5D and Fig. 6). Golgi disassembly occurs transiently dur-
ing mitosis and has the effect of enhancing replication in some
cases of viral infection (1, 3, 51). Intriguingly, Golgi fragmen-
tation has also been observed during infection of a related
coronavirus, MHV, and is associated with syncytium formation
(29, 30). During mitotic Golgi fragmentation, the membrane
components of the Golgi apparatus sequentially redistributes
into isolated fragments that then disassemble further when the
membrane components redistribute into the ER or to ER exit
sites (2). Rather than inducing distribution to the ER, overex-
pression of 3a-GFP causes Gal to localize to isolated frag-
ments, and 3a-GFP and Gal-CFP appear to partially colocalize
(Fig. 5Df, inset, and Fig. 6). These results demonstrate that
SARS-CoV 3a is necessary and sufficient to cause Golgi frag-
mentation.
Vesicles containing 3a-GFP also exhibit markers for late en-
dosomes. When overexpressed, 3a-GFP can be observed to local-
ize to the plasma membrane, as well as to numerous cytoplas-
mic vesicles. We therefore sought to characterize these vesicles
further and to determine their origin. We first observed the
behavior of 3a-GFP in live cells by confocal microscopy. Ves-
icles containing 3a-GFP are dynamic (see Video S1 in the
supplemental material). Although a few vesicles remained sta-
tionary during the observation period, most vesicles exhibited
saltatory movement within the cytoplasm. It was also possible
to observe vesicles moving to and from the plasma membrane,
thus suggesting a possible interaction with the exocytic or en-
docytic pathways.
As mentioned above, we observed that the intracellular ves-
icles containing 3a-GFP only partially colocalized with the
Golgi markers Gal-CFP (Fig. 5D, inset, and Fig. 6) and there-
fore hypothesized that the 3a-protein might localize to the
TGN or endocytic vesicles. In order to test this hypothesis,
3a-GFP or GFP only were co-overexpressed with the TGN
marker, TGN38-CFP. TGN38 is a type I membrane protein
involved in vesicle formation from the trans-Golgi apparatus
and cycles between the TGN and the plasma membrane (4, 22,
43). In addition, we sought to determine whether the vesicles
also contained Lamp1, a major transmembrane glycoprotein
found in late endosomes and lysosomes (8). Vesicles contain-
ing 3a-GFP exhibited extensive colocalization with both TGN38
with Lamp1 (Fig. 7A). To test whether the internal environ-
FIG. 6. SARS-CoV 3a-GFP partially colocalizes with the Golgi
marker Gal-CFP. (A) Vero cells were cotransfected with 3a-GFP and
Gal-CFP and analyzed at 24 hpt by confocal microscopy. 3a-GFP
(A) and Gal-CFP (B) can be seen to partially colocalize in the merged
micrograph (C). White arrows indicate examples of 3a-GFP punctae
that do not colocalize with Gal-CFP.
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ment of these vesicles was also acidic, cells were transfected
with 3a-GFP and stained at 24 h posttransfection (hpt) with
LysoTracker Red DND-99 (Invitrogen/Molecular Probes),
which is a fluorophore in the form of a weakly basic amine that
selectively accumulates in acidic compartments and exhibits
red fluorescence when used appropriately (13). We observed
that many of the 3a-GFP-positive vesicles costained with
LysoTracker Red (Fig. 7B). Together, these data indicate that
FIG. 7. 3a vesicles in live cells contain endosomal markers and are acidic. (A) Vero cells were cotransfected with 3a-GFP, TGN38-CFP, and
Cherry-Lamp1, and live cells were analyzed by confocal microscopy at 24 hpt. Arrows indicate examples of vesicles that contain 3a, TGN38, and
Lamp1. (B) Vero cells were transfected with 3a-GFP and analyzed by confocal microscopy 24 hpi after counterstaining with LysoTracker Red DND
99 according to the manufacturer’s instructions. Two examples of transfected cells are shown. Areas of colocalization appear orange in merge
image.
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3a-GFP vesicles exhibit markers of late endosomes and lyso-
somes.
Overexpression of 3a-GFP causes redistribution of Lamp1
and TGN38. TGN38 is transported on vesicles that bud from
the trans-Golgi apparatus to the plasma membrane and may be
involved in vesicle formation (4). From the plasma membrane,
TGN38 cycles from endocytic vesicles back to the TGN. How-
ever, mislocalization of TGN38 to late endosomes or lyso-
somes has been reported (49). In addition to colocalizing with
TGN38 and Lamp1, we also observed that overexpression of
3a-GFP induces relocalization of TGN38. Compared to cells
expressing GFP only, cells expressing 3a-GFP exhibit an in-
crease in the number of TGN vesicles and show dispersal of
TGN38 from paranuclear Golgi structures (Fig. 8A). We also
observed a similar effect on the localization of Lamp1, with a
noticeable increase in vesicles containing Lamp1 (Fig. 8B).
These results suggest that 3a-GFP induces an accumulation of
vesicles containing TGN38 and Lamp1, which could occur as a
result of increased endocytosis or by inhibiting the transit of
TGN38 from late endosomes to the TGN and therefore caus-
ing mislocalization of the protein to acidic compartments.
Golgi fragmentation is reduced by overexpression of Arf1.
Recently, viruses that cause proliferation of intracellular vesi-
cles but are unrelated to SARS-CoV have been shown to
modulate Arf1 activity during infection. Arf1 is a Golgi body-
associated small Ras-related GTPase that maintains Golgi
structure and function (10). The activity of Arf1 is critical for
assembling coat proteins during vesicle formation by recruiting
COPI to Golgi membranes and regulating clathrin adaptor pro-
teins at the TGN (11, 56). In addition, Golgi fragmentation can
be induced by treating cells with brefeldin A, a fungal metab-
olite that inhibits Arf1 binding to GTP and thus inactivates the
protein (25, 42, 48). We therefore hypothesized that Arf1
might be involved in ORF 3a-induced Golgi fragmentation. To
test this hypothesis, we cotransfected expression constructs for
3a and either empty vector or Arf1. Overexpression of Arf1
potently inhibited 3a-induced Golgi fragmentation (Fig. 9A
and B). Next, using WT SARS-CoV, we infected cells that had
been cotransfected with either Arf1-GFP or control GFP and
the Golgi marker Gal-CFP. In cells that showed overexpres-
sion of Arf1, Gal-CFP was found to localize to intact
paranuclear stacks (Fig. 9C). Therefore, Golgi fragmenta-
tion induced by SARS-CoV likely results from inhibition of
the Arf1 pathway.
DISCUSSION
SARS-CoV infection results in severe disease with high mor-
bidity and mortality. This is in contrast to other human coro-
naviruses, which usually cause a mild upper respiratory tract
infection. As is the case with other coronaviruses, the novel
SARS-CoV accessory proteins that are unique to SARS-CoV
likely contribute to the highly pathogenic nature of the virus.
Thus, further characterization of these proteins is likely to
elucidate mechanisms by which SARS-CoV disrupts cellular
functions and causes disease.
In detailed studies of the 3a protein, we discovered that it
causes intracellular vesicle formation, which is a prominent
feature of cells from SARS patients (15, 53) and is both nec-
essary and sufficient for Golgi fragmentation during virus in-
fection. Vesicles containing ORF 3a protein are acidified com-
partments that also contain the trans-Golgi protein TGN38
and the marker of late endosomes and lysosomes, Lamp1.
These data are consistent with previous findings that ORF 3a
interacts with caveolin and thus the endocytic pathway (40). It
will be important to discover whether the 3a-mediated pro-
FIG. 8. Expression of 3a causes redistribution and accumulation of
Lamp1 and TGN38 in 3a-GFP vesicles. (A) Vero cells were cotrans-
fected with GFP (a to f) or 3a-GFP (g to l) and TGN38-CFP and
analyzed by confocal microscopy at 24 hpt. Examples of cells imaged at
lower (a to c, g to i) and higher (d to f, j to l) magnifications are
depicted. (B) Vero cells were cotransfected with GFP (a to c) or
3a-GFP (d to f) and Cherry-Lamp1 and analyzed in live cells by
confocal microscopy at 24 hpt.
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FIG. 9. Overexpression of Arf1 reduces Golgi fragmentation. (A) Cells were cotransfected with 3a-GFP and empty vector (EV) (left panel) or
Arf1-CFP (right panel, Arf1). After 24 h, cells were stained with an antibody specific for the Golgi marker GM130 (shown in red) and examined
by confocal microscopy. (B) The percent fragmented Golgi of cells in panel A was determined by morphological analysis. (C) Cells were
cotransfected with the Golgi marker Gal-CFP and GFP (left) or Arf1-GFP (right). Transfected cells were infected with the WT SARS-CoV and
examined by confocal microscopy at 24 hpi.
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cesses of Golgi fragmentation and vesicle formation are di-
rectly related or whether they are coincidental disruptions that
occur during infection. Finally, Golgi fragmentation was re-
duced by overexpression of the Golgi regulator protein, Arf1,
suggesting that the functioning of this cellular protein may be
disrupted by ORF 3a.
Positive-strand RNA viruses utilize intracellular membranes
on which to replicate their RNA (28). It is thought that the
membrane acts as a nucleation site for replicase proteins and
polymerases. Many RNA viruses, including the human entero-
virus poliovirus and the group II coronavirus, MHV, cause a
proliferation in cellular membranes or the formation of intra-
cellular vesicles, which is believed to be advantageous for virus
replication (21, 57, 64). Interestingly, poliovirus-induced mem-
brane rearrangement occurs through activation of Arf1 (5, 6).
Electron microscopy analysis of MHV-infected cells shows
the presence of double-membrane vesicles (DMVs), which
are thought to be produced by autophagy. In one study, inhi-
bition of cellular autophagy reduced MHV replication (44).
We found that the formation of intracellular vesicles during
SARS-CoV infection does not affect replication, since deple-
tion of ORF 3a from SARS-CoV abrogated vesicle formation
but did not reduce the levels of viral RNA isolated from the
cells and from the media. Although SARS-CoV may use ve-
sicular membranes as sites of RNA replication (54), intracel-
lular vesicles may not be necessary, and perhaps not even
beneficial, to the virus.
These observations raise the question, if not for replication,
why would SARS-CoV cause such dramatic membrane rear-
rangement? Several possible explanations exist. Evidence sug-
gests that poliovirus, which also induces intracellular vesicles
and DMVs, may utilize the vesicles for nonlytic release of virus
particles (24). One study reported a deficiency in SARS-CoV
release when 3a expression was reduced by RNA interference
(RNAi) (34). However, targeted disruption of group-specific
ORFs by RNAi may also reduce genomic RNA and confound
this interpretation. Our data suggest that release of genomic
RNA is not affected by depletion of ORF 3a, since RNA levels
observed in the media were equivalent for 3a and WT virus.
Alternatively, rearrangement of intracellular membranes can
coincide with disruption of the secretory pathway, which could
facilitate immune evasion by inhibiting antiviral cytokine se-
cretion or antigen presentation by major histocompatibility
complex on the cell surface. Disruption of the secretory path-
way by ORF 3a may require additional viral proteins, since
expression of SARS-CoV ORF 3a protein by replication-defi-
cient particles of Venezuelan equine encephalitis virus does
not inhibit secretion of beta interferon (14). It will also be
important to determine the membrane location on which the
virus replicates in the absence of 3a. Mitochondrial mem-
branes represent a potential site of coronavirus replication.
Several SARS-CoV proteins, including 3b and 9b, localize to
mitochondria (our unpublished observations) and have been
demonstrated to bind replicase proteins nsp8 and nsp14 (62).
Except for the recent study on the 7a protein (52), studies on
death induction by SARS proteins have been limited to trans-
fection/overexpression studies of the individual proteins, most
likely due to the difficulty of working with this lethal pathogen.
Consistent with previous reports, we have observed that over-
expression of 3a is sufficient to cause cell death (31, 39). Im-
portantly, our experiments with SARS-CoV 3a clearly dem-
onstrate that this protein contributes to the cytotoxicity of the
virus and illustrate its biological significance. Residual cytotox-
icity of the SARS-CoV 3a virus may be attributable to the 7a
protein, which is intact in this mutant strain and also contrib-
utes to virus-induced cell death (52). Future studies that in-
corporate additional deletion mutants will be necessary to dis-
cern the mechanism and importance of SARS-CoV-induced
cell death. An animal model that recapitulates the character-
istics of human SARS does not currently exist, and it therefore
remains difficult to determine the relative importance of ORF
3a to SARS-CoV pathogenesis. However, recent adaptation of
SARS-CoV in mice has led to a lethal model that can be used
to investigate the contribution of group-specific ORFs to
SARS disease (47) and thus might provide further insight into
the functioning of these novel proteins.
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